Compare NICM & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NICM | RPID |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | Canada | United States |
| Employees | 25 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 84.8M |
| IPO Year | N/A | 2021 |
| Metric | NICM | RPID |
|---|---|---|
| Price | $5.17 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 4.4K | ★ 229.2K |
| Earning Date | 11-27-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | $355.99 | $16.95 |
| Revenue Next Year | $161.43 | $17.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $5.00 | $0.76 |
| 52 Week High | $7.00 | $4.94 |
| Indicator | NICM | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 29.35 | 27.64 |
| Support Level | N/A | N/A |
| Resistance Level | $5.68 | $2.18 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 2.35 | 7.36 |
Nicola Mining Inc is a junior exploration and custom milling company that is engaged in the business of identification, acquisition, and exploration of mineral property interests, together with custom milling partnerships at its Merritt Mill. The company holds interests in various claims at the following properties: the Treasure Mountain Property, New Craigmont Property, and Dominion Creek Property. Its portfolio of producing assets and development projects is mainly composed of copper, gold, and silver properties spread across British Columbia, Canada.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.